首页 > 专栏 > The Lancet Infectious Diseases The Lancet Infectious Diseases 共 190 条资讯 [Corrections] Correction to Lancet Infect Dis 2026; 26: 1095 [Corrections] Correction to Lancet Infect Dis 2026; published online Oct 12. https://doi.org/10.1016/S1473-3099(26)00469-X [Comment] Dilemmas in the management of fluoroquinolone-resistant tuberculosis [Review] Effectiveness of respiratory syncytial virus immunisation in practice [Corrections] Correction to Lancet Infect Dis 2026; published online Oct 14. https://doi.org/10.1016/S1473-3099(26)00572-4 [Corrections] Correction to Lancet Infect Dis 2026; published online Oct 15. https://doi.org/10.1016/S1473-3099(26)00574-8 [Articles] Safety and immunogenicity of an adenoviral-vectored vaccine against Crimean–Congo haemorrhagic fever in the UK (CCHF01): an open-label, first-in-human, non-randomised, phase 1 clinical trial [Comment] The inequality of adverse pregnancy outcomes related to Oropouche virus infections [Articles] Oropouche virus infection in pregnant women in Rio de Janeiro, Brazil: a prospective cohort study [Media Watch] Who fills the silence in a crisis [Newsdesk] Disruption of HIV services in Ukraine [Correspondence] Cross-neutralisation of authentic Ebola virus and Bundibugyo virus following natural infection or Ervebo vaccination [Correspondence] Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination [Personal View] Second-season observations after prophylaxis in the evaluation of the impact of nirsevimab in Galicia (NIRSE-GAL) study: mechanistic interpretation and implications for respiratory syncytial virus prevention strategy [Personal View] Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks [Media Watch] Putting emotion back into pandemic numbers [Corrections] Correction to Lancet Infect Dis 2026; published online Oct 1. https://doi.org/10.1016/S1473-3099(26)00470-6 [Media Watch] Who fills the silence in a crisis [Articles] Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace) [Personal View] When the fungus is susceptible, but the patient is not: reading antifungal susceptibility from bench to bedside 123…10下一页 » 相关分类 The Lancet Infectious Diseases The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi 38号车评中心